Home/Filings/4/0001209191-13-052737
4//SEC Filing

ROCHESTER MEDICAL CORPORATION 4

Accession 0001209191-13-052737

CIK 0000868368operating

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 12:34 PM ET

Size

17.3 KB

Accession

0001209191-13-052737

Insider Transaction Report

Form 4
Period: 2013-11-14
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2013-11-14$8.73/sh10,000$87,3000 total
    Exercise: $11.27From: 2009-02-03Exp: 2019-02-03Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2013-11-14$9.28/sh16,000$148,4800 total
    Exercise: $10.72From: 2011-01-27Exp: 2021-01-27Common Stock (16,000 underlying)
  • Disposition to Issuer

    Common Stock

    2013-11-14$20.00/sh24,642$492,8400 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2013-11-14$7.70/sh40,000$308,0000 total
    Exercise: $12.30From: 2006-11-21Exp: 2016-11-21Common Stock (40,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2013-11-14$8.77/sh10,000$87,7000 total
    Exercise: $11.23From: 2008-02-06Exp: 2018-02-05Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2013-11-14$7.73/sh12,000$92,7600 total
    Exercise: $12.27From: 2010-01-28Exp: 2020-01-28Common Stock (12,000 underlying)
Footnotes (4)
  • [F1]On November 14, 2013, in connection with the acquisition of Rochester Medical Corporation (the "Company") by C. R. Bard, Inc., a New Jersey corporation ("Bard") pursuant to the Agreement and Plan of Merger dated September 3, 2013 (the "Merger Agreement") among the Company, Bard and a wholly owned subsidiary of Bard, at the effective time of the merger contemplated by the Merger Agreement (the "Merger"), these shares of Company common stock were cancelled and converted into the right to receive a cash payment of $20.00 per share, without interest and less any applicable withholding taxes.
  • [F2]Includes restricted stock awards.
  • [F3]Pursuant to the Merger Agreement, upon the effectiveness of the Merger 10,642 shares of restricted stock were cancelled in exchange for the right to receive $20.00 per share, without interest and less any applicable withholding taxes.
  • [F4]These options were 100% vested on date of grant. Pursuant to the Merger Agreement, upon the effectiveness of the Merger the vesting of these options was accelerated and they were cancelled in exchange for the right to receive a cash payment per option equal to the excess of $20.00 over the per share exercise price of the option.

Issuer

ROCHESTER MEDICAL CORPORATION

CIK 0000868368

Entity typeoperating
IncorporatedMN

Related Parties

1
  • filerCIK 0000868368

Filing Metadata

Form type
4
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 12:34 PM ET
Size
17.3 KB